» Articles » PMID: 37053489

Preparative Electrophoresis for HDL Particle Size Separation and Intact-Mass Apolipoprotein Proteoform Analysis

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2023 Apr 13
PMID 37053489
Authors
Affiliations
Soon will be listed here.
Abstract

The most abundant proteins on high-density lipoproteins (HDLs), apolipoproteins A-I (APOA1) and A-II (APOA2), are determinants of HDL function with 15 and 9 proteoforms (chemical-structure variants), respectively. The relative abundance of these proteoforms in human serum is associated with HDL cholesterol efflux capacity, and cholesterol content. However, the association between proteoform concentrations and HDL size is unknown. We employed a novel native-gel electrophoresis technique, clear native gel-eluted liquid fraction entrapment electrophoresis (CN-GELFrEE) paired with mass spectrometry of intact proteins to investigate this association. Pooled serum was fractionated using acrylamide gels of lengths 8 and 25 cm. Western blotting determined molecular diameter and intact-mass spectrometry determined proteoform profiles of each fraction. The 8- and 25 cm experiments generated 19 and 36 differently sized HDL fractions, respectively. The proteoform distribution varied across size. Fatty-acylated APOA1 proteoforms were associated with larger HDL sizes (Pearson's = 0.94, = 4 × 10) and were approximately four times more abundant in particles larger than 9.6 nm than in total serum; HDL-unbound APOA1 was acylation-free and contained the pro-peptide proAPOA1. APOA2 proteoform abundance was similar across HDL sizes. Our results establish CN-GELFrEE as an effective lipid-particle separation technique and suggest that acylated proteoforms of APOA1 are associated with larger HDL particles.

Citing Articles

Mass spectrometry-intensive top-down proteomics: an update on technology advancements and biomedical applications.

Xu T, Wang Q, Wang Q, Sun L Anal Methods. 2024; 16(28):4664-4682.

PMID: 38973469 PMC: 11257149. DOI: 10.1039/d4ay00651h.


Proteomics-The State of the Field: The Definition and Analysis of Proteomes Should Be Based in Reality, Not Convenience.

Coorssen J, Padula M Proteomes. 2024; 12(2).

PMID: 38651373 PMC: 11036260. DOI: 10.3390/proteomes12020014.

References
1.
Melani R, Seckler H, Skinner O, do Vale L, Catherman A, Havugimana P . CN-GELFrEE - Clear Native Gel-eluted Liquid Fraction Entrapment Electrophoresis. J Vis Exp. 2016; (108):53597. PMC: 4828206. DOI: 10.3791/53597. View

2.
Wilkins J, Seckler H . HDL modification: recent developments and their relevance to atherosclerotic cardiovascular disease. Curr Opin Lipidol. 2018; 30(1):24-29. PMC: 6439474. DOI: 10.1097/MOL.0000000000000571. View

3.
Asztalos B, Schaefer E . High-density lipoprotein subpopulations in pathologic conditions. Am J Cardiol. 2003; 91(7A):12E-17E. DOI: 10.1016/s0002-9149(02)03383-0. View

4.
Honda K, Srivastava S . Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer. Biomark Med. 2016; 10(11):1197-1207. PMC: 5493967. DOI: 10.2217/bmm-2016-0209. View

5.
Dos Santos Seckler H, Fornelli L, Mutharasan R, Thaxton C, Fellers R, Daviglus M . A Targeted, Differential Top-Down Proteomic Methodology for Comparison of ApoA-I Proteoforms in Individuals with High and Low HDL Efflux Capacity. J Proteome Res. 2018; 17(6):2156-2164. PMC: 6162093. DOI: 10.1021/acs.jproteome.8b00100. View